Iryna Kriachok

Years Active: 2024-2024
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Pier Luigi Luigi Zinzani, Huaqing Wang, Jifeng Feng, Tae Min Kim, Rong Tao, Huilai Zhang, Laura Maria Fogliatto, Clara Maluquer Artigal, Muhit Özcan, Eduardo Patricio Yanez Ruiz, Won Seog Kim, Dmitry Kirtbaya, Iryna Kriachok, Felipe Maciel, Hongwei Xue, Krimo Bouabdallah, Charles Phelps, Shalini Chaturvedi, Anke Weispfenning, Peter N Morcos, Fatuma Catherine Atieno Odongo, Viktoriya Buvaylo, Barrett H Childs, Martin Dreyling, Matthew J Matasar, Paola Ghione
CHRONOS-4: Phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma. Blood advances (2024)
Pier Luigi Luigi Zinzani, Huaqing Wang, Jifeng Feng, Tae Min Kim, Rong Tao, Huilai Zhang, Laura Maria Fogliatto, Clara Maluquer Artigal, Muhit Özcan, Eduardo Patricio Yanez Ruiz, Won Seog Kim, Dmitry Kirtbaya, Iryna Kriachok, Felipe Maciel, Hongwei Xue, Krimo Bouabdallah, Charles Phelps, Shalini Chaturvedi, Anke Weispfenning, Peter N Morcos, Fatuma Catherine Atieno Odongo, Viktoriya Buvaylo, Barrett H Childs, Martin Dreyling, Matthew J Matasar, Paola Ghione
CHRONOS-4: Phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma. Blood advances (2024)

Iryna Kriachok.css-eqlu8i{font-size:small;padding-left:4px;}